Description
Cardiomyocytes from human pluripotent stem cells could revolutionise biomedicine. Advances in human PSC isolation, Cas9/CRISPR genome engineering and human PSC derived Cardiomyocytes differentiation have improved patient care, progressed drugs to clinic and opened a new era in safety pharmacology. The QualiStem® IPS Cell Cardiomyocyte Differentiation Kit consists of a set of supplements that enable efficient differentiation of human pluripotent stem cells to contracting cardiomyocytes. This kit maximizes workflow efficiency and is applicable for drug toxicity and small molecule screening. This kit has been tested on multiple induced pluripotent stem cell lines